Genomic Imbalances Associated with Acquired Resistance to Platinum Analogues
- 31 July 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (1) , 77-84
- https://doi.org/10.1016/s0002-9440(10)65102-4
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Automatic correction of the interfering effect of unsuppressed interspersed repetitive sequences in comparative genomic hybridization analysisCytometry, 1997
- Increased expression of T‐plastin gene in cisplatin‐resistant human cancer cells: identification by mRNA differential displayFEBS Letters, 1996
- Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell LineJournal of Biological Chemistry, 1996
- Characterization of high mobility group protein binding to cisplatin-damaged DNABiochemical and Biophysical Research Communications, 1992
- Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid TumorsScience, 1992
- ERCC1 and ERCC2 Expression in Malignant Tissues From Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 1992
- Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.Journal of Clinical Investigation, 1990
- Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cellsGynecologic Oncology, 1990
- Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracilEuropean Journal of Cancer and Clinical Oncology, 1990
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969